$InspireMD(NSPR.US)$InspireMD Announces Abstract Of One-year Follow-up Results From C-GUARDIANS U.S. Investigational Device Exemption Clinical Trial Accepted For Presentation At LINC 2024 Benzinga· 1 min ago
$InspireMD(NSPR.US)$InspireMD Receives CE Mark Recertification Under EU's New Medical Device Regulation (MDR) Regulatory Framework 3 MINUTES AGO, 7:00 AM EST VIA GLOBENEWSWIRE
InspireMD insiders' stock purchases indicate a positive company outlook. Yet, lack of profits over the last twelve months may concern investors. Insider ownership suggest interests' alignment with shareholders, raising perceptions of an undervalued share price.
$InspireMD(NSPR.US)$Director ROUBIN GARY S purchased 50,000 shares of Common Stocks on Nov 30, 2023 at an average price of $2.5308 for a total value of $126.54K.
$InspireMD(NSPR.US)$InspireMD Announced Its Support For Centers For Medicare & Medicaid Services Final National Coverage Determination Which Expands Coverage Of Carotid Artery Stenting And Transcarotid Artery Revascularization To Include Asymptomatic & Standard Risk Patients
InspireMD股票討論區
Benzinga· 1 min ago
3 MINUTES AGO, 7:00 AM EST
VIA GLOBENEWSWIRE
Benzinga· 1 min ago
暫無評論